Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A Ophthalmic Gel in Moderate-to-Severe Dry Eye
CTR20200805Phase 3Completed
- Sponsor
- Zhaoke Pharmaceutical (Hefei) Co., Ltd.
- Start
- Jun 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in dry eye syndrome (DED), sponsored by Zhaoke Pharmaceutical (Hefei) Co., Ltd.. Started Jun 2020; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20200805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200805.